# Immix Biopharma, Inc.: Form 8-K, filed Jun 14, 2024

- Company: [Immix Biopharma, Inc.](/companies/immx.md) (CIK 1873835)
- Form: 8-K
- Filed: 2024-06-14
- Accepted by EDGAR: Jun 14, 2024, 17:30 ET
- Period: 2024-06-11
- Accession: 0001493152-24-023947
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/form8-k.htm

Filed Jun 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-023947. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.